Bacterial concentrations in pus and infected peritoneal fluid -: implications for bactericidal activity of antibiotics

被引:104
作者
König, C
Simmen, HP
Blaser, J
机构
[1] Univ Zurich Hosp, Dept Med, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Surg, CH-8091 Zurich, Switzerland
关键词
D O I
10.1093/jac/42.2.227
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Little is known about how many bacteria are present at an infectious focus at the onset of antibiotic therapy. The number of cfu was determined in pus and infected peritoneal fluids obtained from 41 patients. Pathogens were detected in 71% of specimens. There were high concentrations of bacteria in culture-positive samples, in both soft-tissue and peritoneal infections, averaging 2 x 10(8) cfu/mL. These concentrations were much higher than the standard inoculum size used in in-vitro susceptibility tests, 5 x 10(5) cfu/mL. The impact of this discrepancy on antibacterial efficacy was studied with amikacin, ciprofloxacin, imipenem and piperacillin against Escherichia coli and Staphylococcus aureus. The inhibitory and bactericidal activities of amikacin and ciprofloxacin determined with high inocula were two to four times lower than with standard inocula, whereas the activity of piperacillin was diminished at least 128-fold. Similar activity was observed with these drugs in Mueller-Hinton broth and peritoneal fluid. The bactericidal activity of imipenem was reduced in peritoneal fluid. Thus, conditions prevailing at the infection site may compromise antibiotic activity determined in vitro.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 22 条
[1]
STAPHYLOCOCCUS-AUREUS MICROCAPSULE EXPRESSION ATTENUATES BACTERIAL VIRULENCE IN A RAT MODEL OF EXPERIMENTAL ENDOCARDITIS [J].
BADDOUR, LM ;
LOWRANCE, C ;
ALBUS, A ;
LOWRANCE, JH ;
ANDERSON, SK ;
LEE, JC .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) :749-753
[2]
BILTON D, 1995, EUR RESPIR J, V8, P948
[3]
BOLMSTROM A, 1996, 36 INT C ANT AG CHEM, P67
[4]
BROOK I, 1989, REV INFECT DIS, V11, P361
[5]
BROOK I, 1981, LARYNGOSCOPE, V91, P250
[6]
In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model [J].
Bugnon, D ;
Potel, G ;
Xiong, YQ ;
Caillon, J ;
Kergueris, MF ;
LeConte, P ;
Baron, D ;
Drugeon, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1164-1169
[7]
EVALUATION OF BRONCHOSCOPIC TECHNIQUES FOR THE DIAGNOSIS OF NOSOCOMIAL PNEUMONIA [J].
CHASTRE, J ;
FAGON, JY ;
BORNETLECSO, M ;
CALVAT, S ;
DOMBRET, MC ;
ALKHANI, R ;
BASSET, F ;
GIBERT, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (01) :231-240
[8]
TOLERANCE OF PSEUDOMONAS-AERUGINOSA TO KILLING BY CIPROFLOXACIN, GENTAMICIN AND IMIPENEM INVITRO AND INVIVO [J].
DAVEY, P ;
BARZA, M ;
STUART, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 (04) :395-404
[9]
THE INOCULUM EFFECT WITH GRAM-NEGATIVE BACTERIA INVITRO AND INVIVO [J].
DAVEY, PG ;
BARZA, M .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 (05) :639-644